Home › Kanser sa Ovary › Rhode Island › Providence

Pag-aaral pangklinika para sa Kanser sa Ovary sa Providence, RI

Isang pag-aaral para sa Kanser sa Ovary ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Providence. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Nagre-recruitPhase 2

Women and Infants Hospital, Providence
Roger Williams Medical Center, Providence

Lahat ng edad · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT05564377

Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors

Nagre-recruitPhase 1/2

Research Site, Providence

Edad 18 hanggang 130 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT05797168

TLR9 Immunotherapy for Peritoneal Carcinomatosis

Nagre-recruitPhase 1

Rhode Island and the Miriam Hospitals (Brown University Health), Providence

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT07658196

A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies

Nagre-recruitPhase 2

Women & Infants Hospital /ID# 277930, Providence

Edad 18 pataas · Kababaihan · Na-update Okt 1, 2026 · NCT07024784

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

Nagre-recruitPhase 2

Women & Infants Hospital /ID# 274716, Providence

Edad 18 pataas · Kababaihan · Na-update Set 29, 2026 · NCT06890338

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

Nagre-recruitPhase 3

Women & Infants Hospital, Providence

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07213804

A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)

Nagre-recruitPhase 3

Women & Infants Hospital ( Site 0001), Providence

Edad 18 pataas · Kababaihan · Na-update Set 17, 2026 · NCT07318558

A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

Nagre-recruitPhase 3

Women & Infants Hospital ( Site 0050), Providence

Edad 18 pataas · Kababaihan · Na-update Set 3, 2026 · NCT06824467

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

Nagre-recruit

Women and Infants Hospital, Providence

Edad 35 hanggang 50 · Kababaihan · Na-update Ago 7, 2026 · NCT04251052

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

Nagre-recruitPhase 3

Women and Infants Hospital, Providence

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 7, 2026 · NCT06580314

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Nagre-recruitPhase 1/2

Women and Infants Hospital of Rhode Island, Providence

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 4, 2026 · NCT05579366

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

Nagre-recruitPhase 2

Lifespan Cancer Institute - Rhode Island Hospital, Providence

Edad 8 pataas · Lahat ng kasarian · Na-update Hul 27, 2026 · NCT05503797

Use of CA125 and Complementary Biomarkers for the Early Detection of Ovarian Cancer in Low Risk Women

Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo

Women's and Infant's Hospital, Providence

Edad 50 hanggang 74 · Kababaihan · Na-update May 6, 2026 · NCT00539162

A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer

Nagre-recruitPhase 1

Site 0191, Providence

Edad 18 pataas · Kababaihan · Na-update Abr 7, 2026 · NCT04516447

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Nagre-recruitObservasyonal na pag-aaral

Massive Bio SYNERGY-AI site, Providence

Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

Pag-aaral para sa Kanser sa Ovary sa ibang lungsod

Iba pang pag-aaral sa Providence

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.